purpose. To compare the use of ropivacaine versus bupivacaine for 3-in-1 block during total knee arthroplasty (TKA) in terms of efficacy and safety (lack of toxicity). Methods. 14 men and 26 women aged 58 to 77 (median, 70) years who had the American Society of Anesthesiologists (ASA) grades I to III physical status were randomised to receive ropivacaine (n=20) or bupivacaine (n=20) of a concentration of 0.5% for 3-in-1 block during TKA. The dosage was 0.5 ml/kg. In addition, a sciatic nerve block (20 ml of prilocaine 1%) was used. The onset of the block, duration of postoperative analgesia, level of motor block, and any side-effects were compared. results. The median time to onset of block was significantly shorter in those receiving ropivacaine than bupivacaine (13 vs. 17.5 minutes, p<0.001), but the levels of motor blockade were not significantly different (p=0.355). Complete analgesia was achieved throughout the procedure. There was no significant difference between the ropivacaine and bupivacaine groups in terms of the mean duration of analgesia (398 vs. 367 minutes, p=0.62), the mean VAS scores at all time points, and the mean total morphine consumption. One patient in the ropivacaine group developed a joint haematoma and 2 patients in the bupivacaine group had excessive wound drainage. Both conditions resolved after antibiotic use. conclusion. Ropivacaine and bupivacaine showed similar anesthetic and analgesic effects, but the former had a significantly faster onset time.
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blockade duration and quality, but ropivacaine has greater sensory-to-motor selectivity, less central nervous system and cardiac toxicity, a wider margin of safety, lower intensiveness, and longer duration of motor block. 7, 8 The 3-in-1 block involves the blockade of the femoral nerve, lateral femoral cutaneous nerve, and obturator nerve using a long-acting local anaesthetic agent (such as bupivacaine or ropivacaine). 9 It provides adequate surgical anaesthesia and postoperative analgesia, and has been applied for major lower-limb surgeries around the knee. 5 This study compared the use of ropivacaine versus bupivacaine for 3-in-1 block during total knee arthroplasty (TKA) in terms of efficacy and safety (lack of toxicity).
Materials and Methods
This study was approved by the ethics committee of our hospital. Informed consent was given by each patient. 14 men and 26 women aged 58 to 77 (median, 70) years who had American Society of Anesthesiologists 10 (ASA) grades I to III physical status were randomised to receive intravenous ropivacaine (n=20) or bupivacaine (n=20) for 3-in-1 block during TKA for tricompartmental osteoarthritis (Table) . Randomisation was based on a computergenerated sequence with a one-to-one allocation ratio.
Patients with a history of allergy to local anaesthetic agents, severe neurological, cardiovascular, respiratory, renal or hepatic diseases, malignancy, coagulopathy, infection at the site of block placement, previous knee operations, or severe ambulatory problems were excluded, as were those with a history of opioid dependence, inability to understand the pain scale or the use of the patientcontrolled analgesia device (PCA).
Temazepam (10 mg) was given one hour before the procedure. Vital signs were continuously monitored according to patients' ASA grades. Two intraveneous cannulas were used: a 16-gauge for fluid infusion and a 20-gauge for propofol infusion. Propofol was commenced before nerve block placement to provide sedation during surgery.
A nerve stimulator and a 50-mm insulated needle were used for the 3-in-1 block. The patient was lightly sedated and positioned supine. The puncture site was located about 2 cm below the inguinal ligament and 1 cm lateral to the femoral artery. After eliciting a quadriceps femoris motor response (i.e. cephalad patellar movement) at 0.5 mA (2 Hz, 100 μs), the local anaesthetic (0.5 ml/kg of 0.5%) was injected.
Digital pressure was applied distal to the needle entry site in order to increase the fluid spread and blockade of the femoral, lateral femoral cutaneous, and obturator nerves. The sciatic nerve block was performed with a 21-gauge (150 mm) needle through the anterior approach under the guidance of a nerve stimulator. 11, 12 After eliciting a stimulation of the common peroneal nerve (dorsiflexion or eversion of the foot) or tibial nerve (plantar flexion and inversion of the foot and toes) at 0.5 mA (2 Hz, 100 μs), 20 ml of 1% prilocaine (200 mg) was injected. To prevent development of any side-effects, doses of >600 mg should be avoided. 13 1.5 g of intravenous cefuroxime was administrated 20 to 30 minutes before skin incision and every 8 hours for 48 hours. A thigh tourniquet was applied. A midline skin incision was made, and the knee was exposed through the medial parapatellar capsule. The distal femur and proximal tibia were prepared according to the mechanical axis. Bone cuts were made to create equal flexion and extension gaps. The posterior cruciate ligament and the patella were retained. As all the knees had a preoperative varus deformity, the medial collateral ligament was released. The implants were fixed with bone cement, and a polyethylene insert was introduced to achieve proper balance of the knee in both the mediolateral and anteroposterior direction. The wound was closed in layers over a suction drain, which was removed on postoperative day 2.
Physiotherapy and continuous passive movement were initiated on day 1. Partial weight bearing and range-of-motion exercises were allowed as tolerated. Thromboprophylaxis consisted of low-molecularweight heparin along with compression stockings for 6 weeks. Patients were discharged on day 6.
Loss of sensation to cold/warm touch in the thigh and adductor weakness was assessed every 5 minutes until satisfactory anaesthesia was achieved (at L2-4 or L5-S1). Motor blockade was assessed using the Bromage scale (0=full flexion of feet and knees, 1=able to move knees only, 2=able to move feet only, and 3=unable to move feet or knees). The quality of the 3-in-1 block was evaluated by the surgeon and anaesthetist.
Postoperatively, patients received intravenous patient-controlled analgesia (1 mg morphine every 5 minutes with a maximum dose of 48 mg in 4 hours) for 2 days, followed by oral medications. Any residual pain was assessed using the visual analogue scale (VAS) for pain. The duration effect of each block was defined as the time between ropivacaine/bupivacaine injection and the first request for analgesia.
All variables were tested for normality with the Kolmogorov-Smirnov test (the value of 0.200 was considered the lower bound of true significance). Categorical data were presented as proportions and analysed using the Chi-squared test. Normally distributed continuous numeric data were compared using the Student's t test. The Mann-Whitney U test was used to compare non-normally distributed numeric variables. Statistical significance was assumed for p<0.05. The sample size was estimated by priori power analysis at a power of 0.80. At least 20 patients in each group were needed to provide 80% power to detect a 5-minute difference in the onset of anaesthesia between groups at the 0.05 significance level.
results
The patient age, ASA score, gender ratio, surgical time, and volume of injected local anaesthetics in the 2 groups were comparable (Table) . The median (range) time to onset of the block was significantly shorter in those receiving ropivacaine than bupivacaine (13 [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] vs. 17.5 [10-31] minutes, p<0.001), but the levels of motor blockade (Bromage scale) were not significantly different (p=0.355). Complete analgesia was achieved throughout the procedure. There was no significant difference between the ropivacaine and bupivacaine groups in terms of the mean duration of analgesia (398±232 vs. 367±159 minutes, p=0.62), the mean VAS scores at all time points (p=0.163 at 12 hours, p=0.821 at 24 hours, p=0.502 at 36 hours, p=0.816 at 48 hours), and the mean total morphine consumption during the first 24 hours (3±2 vs. 4±3 mg, p=0.176) and after 48 hours (10±13 vs. 12±12 mg, p=0.625).
During surgery, the levels of arterial blood pressure, heart rate, and haemoglobin oxygen saturation were within normal limits. No signs of local anaesthetic, cardiovascular, or central nervous system toxicity (e.g. cardiac arrhythmia, dizziness, mouth numbness) were observed in any patient.
One patient in the ropivacaine group developed a joint haematoma and 2 patients in the bupivacaine group had excessive wound drainage. Both conditions resolved after antibiotic use.
discussion
Selection of the optimal local anaesthetic for the 3-in-1 block should consider the time of onset, duration of blockade, and safety of the injected drug. Inclusion of the obturator nerve in the block remains controversial, owing to the low success rate of obturator nerve blockade, 9,14-16 but block failure is not necessarily associated with poor results. 17, 18 The proper amount of the injected local anaesthetic is also debatable. Increased fluid volumes might or might not influence the quality of block. 19, 20 There was no difference in the extension of the 3-in-1 block between 20 and 40 ml of mepivacaine 1%. 16 In 50% of the cases, the mean minimum local anaesthetic volume for successful femoral nerve block was 14±2 (95% CI, 12-16) ml in the ropivacaine group and 15±2 (95% CI, 13-17) ml in the bupivacaine group (p=0.155). 19 Ropivacaine tends to have a quicker onset time than bupivacaine (by 2 to 15 minutes), 18, 21 but the latter exerts a longer duration of anaesthesia (approximately 4 hours). 18 The 0.75% ropivacaine had a significantly shorter onset time than 0.5% bupivacaine when used for combined sciatic-femoral nerve block, but the resolution time of the motor block, the onset of postsurgical pain, and the time until the first request for analgesia are comparable. 17 In a rat study, 22 the duration of the regional sensory anaesthesia was similar when equimolar doses of bupivacaine and ropivacaine were used. The main advantage of ropivacaine over bupivacaine is its lesser potential for cardiotoxicity. In a dog model, convulsive doses of ropivacaine were less arrhythmogenic than those of bupivacaine. 23 In 12 volunteers who received intravenous ropivacaine or bupivacaine up to a maximal dose of 150 mg, the former caused less central nervous system symptoms and could be tolerated at a larger total dosage than bupivacaine. 8 However, toxicity was noted when ropivacaine was administered along with lidocaine. 8 A case of sudden cardiac arrest was reported in a 34-year-old man after an interscalene brachial plexus block with a mixture of 150 mg of ropivacaine and 360 mg of lidocaine. 24 Although severe adverse reactions to ropivacaine and lidocaine were rare, serious cardiovascular complications could occur after their combined use. 24 The 3-in-1 block can cause several local complications (incomplete nerve blockade, direct nerve trauma with potential quadriceps wasting, local haematoma, ischaemic injury, and infection). 25 In 4 patients with a fall and further injury after a 3-in-1 block, the legs exhibited reduced 2-point discrimination, pain, and/or light touch sensation, and full weight bearing was delayed. 26 Therefore, patients having a 3-in-1 block should be examined postoperatively to ensure full motor recovery, proper proprioceptive function, and normal neurologic behaviour before mobilisation.
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